Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (9451)	3/30/1999 12:42:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Whoa there pilgrim!

To: aknahow who wrote (9451)	3/30/1999 12:55:00 PM
From: LarryS	Respond to of 17367

Maybe XOMA is waiting for Phase III to be completed and then release a pr announcement that will WAKE UP the investment community......end of Phase III for mening, starting of Phase III for hu1124, update on Phase III trauma(DSMB recommendations?)...anything else? Wouldn't that be great?!?...am I just dreaming? Being there in Berkeley it would be impossible for Bayer to miss the announcement...maybe a buyout bid for XOMA's breakthru products is being comtemplated, IF the trials are successful.....just don't sell out for under $40. .